PT  - JOURNAL ARTICLE
AU  - Kevin J. Donohoe
AU  - Brett J. Carroll
AU  - David K.V. Chung
AU  - Elizabeth H. Dibble
AU  - Emilia Diego
AU  - Francesco Giammarile
AU  - Frederick D. Grant
AU  - Stephen Y. Lai
AU  - Hannah Linden
AU  - Megan E. Miller
AU  - Neeta Pandit-Taskar
AU  - Nicholas E. Tawa, Jr.
AU  - Sergi Vidal-Sicart
TI  - Summary: Appropriate Use Criteria for Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema
AID  - 10.2967/jnumed.123.265560
DP  - 2023 Mar 01
TA  - Journal of Nuclear Medicine
PG  - jnumed.123.265560
4099  - http://jnm.snmjournals.org/content/early/2023/03/23/jnumed.123.265560.short
4100  - http://jnm.snmjournals.org/content/early/2023/03/23/jnumed.123.265560.full
AB  - Expert representatives from 11 professional societies, as part of an autonomous work group, researched and developed appropriate use criteria (AUC) for lymphoscintigraphy in sentinel lymph node mapping and lymphedema. The complete findings and discussions of the work group, including example clinical scenarios, were published on October 8, 2022, and are available at https://www.snmmi.org/ClinicalPractice/ content.aspx?ItemNumber=42021. The complete AUC document includes clinical scenarios for scintigraphy in patients with breast, cutaneous, and other cancers, as well as for mapping lymphatic flow in lymphedema. Pediatric considerations are addressed. These AUC are intended to assist health care practitioners considering lymphoscintigraphy. Presented here is a brief overview of the AUC, including the rationale and methodology behind development of the document. For detailed findings of the work group, the reader should refer to the complete AUC document online.